Hepatocellular carcinoma (HCC) is one of the few cancers in which a continued increase in
incidence has been observed over several years. As such, there has been a focus on safe …

Advances in radiotherapy technologies have enabled more precise target guidance,
improved treatment verification, and greater control and versatility in radiation delivery …

The NCCN Guidelines for Hepatobiliary Cancers focus on the screening, diagnosis, staging,
treatment, and management of hepatocellular carcinoma (HCC), gallbladder cancer, and …

The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for
cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel …

Purpose To describe outcomes of prospective trials of stereotactic body radiotherapy (SBRT)
for hepatocellular carcinoma (HCC). Patients and Methods Two trials of SBRT for patients …

Background & Aims Few studies have been conducted to compare the efficacies of
stereotactic body radiation therapy (SBRT) and radiofrequency ablation (RFA). Thus, in this …

PURPOSE: To evaluate the safety and efficacy of stereotactic body radiotherapy (SBRT) for
the treatment of primary hepatocellular carcinoma (HCC). METHODS AND MATERIALS …

BACKGROUND: The objective of this study was to evaluate the efficacy and safety of
stereotactic body radiation therapy (SBRT) as a local salvage treatment after incomplete …

Background. Since 2005, we have treated hepatocellular carcinoma (HCC) with stereotactic
body radiotherapy (SBRT) uniformly at two dose levels, according to baseline liver function …

Importance Patients with preexisting liver dysfunction could benefit the most from
personalized therapy for liver tumors to balance maximal tumor control and minimal risk of …